{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-biological-sample-collection-and-processing”
},
“headline”: “SOP for Biological Sample Collection and Processing”,
“description”: “This SOP defines standardized procedures for the collection, labeling, processing, and documentation of biological samples in clinical trials, ensuring compliance with ICH GCP, FDA, EMA, CDSCO, and WHO requirements. It includes sample handling, centrifugation, freezing, and biospecimen chain of custody.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Biological Sample Collection and Processing

Purpose

The purpose of this SOP is to establish standardized, regulatory-compliant procedures for the collection, labeling, processing, storage, and documentation of biological samples in clinical trials. Proper handling of biospecimens ensures subject safety, sample integrity, and reliability of laboratory test results.

Scope

This SOP applies to all investigators, clinical staff, laboratory technicians, and CROs involved in the collection and processing of biological samples (blood, urine, saliva, tissue, genetic material) from subjects participating in clinical trials. It covers informed consent, aseptic collection, labeling, processing, storage, transport, documentation, and chain of custody.

Responsibilities

• Investigator: Ensures sample collection is ethically approved and compliant with consent.
• Clinical Staff: Performs aseptic sample collection and records procedures.
• Laboratory Technicians: Process and store samples under validated conditions.
• CRA: Verifies sample management compliance during monitoring visits.
• QA: Audits sample collection and processing records for GCP compliance.
• Courier/Vendors: Maintain sample transport integrity and document chain of custody.

Accountability

The Principal Investigator (PI) is accountable for ensuring compliance with regulatory guidelines for biological sample handling. Laboratory managers are accountable for sample processing and storage integrity. QA is accountable for oversight and inspection readiness.

Procedure

1. Informed Consent and Ethics
1.1 Ensure subjects have provided informed consent specific to sample collection, processing, and future use (if applicable).
1.2 Maintain consent forms in the Investigator Site File (ISF).

2. Sample Collection
2.1 Collect samples using aseptic techniques, minimizing pre-analytical variability.
2.2 Record sample type, volume, and collection time in Sample Collection Log (Annexure-1).
2.3 Use appropriate collection containers (vacutainers, sterile jars, tissue containers).
2.4 Apply subject ID labels immediately after collection.

3. Sample Processing
3.1 Process blood samples within 2 hours of collection (centrifugation at specified RPM and duration).
3.2 For tissue samples, fix or preserve as per protocol requirements.
3.3 Prepare aliquots where required and label each with subject ID, sample type, date, and time.
3.4 Document processing steps in Sample Processing Log (Annexure-2).

4. Sample Storage
4.1 Store samples at validated conditions (e.g., −20°C, −80°C, liquid nitrogen) as defined by protocol.
4.2 Maintain continuous temperature monitoring with alarm systems.
4.3 Document storage location in Sample Storage Log (Annexure-3).

5. Transport
5.1 Package samples per IATA regulations for biological substances.
5.2 Maintain cold chain integrity during transport.
5.3 Complete Chain of Custody Log (Annexure-4).

6. Documentation
6.1 Maintain Sample Documentation File containing collection forms, logs, and transport records.
6.2 Verify accuracy during monitoring visits.

7. Deviations and Non-Compliance
7.1 Record deviations (e.g., delayed processing, temperature excursions) in Sample Deviation Log (Annexure-5).
7.2 Investigate deviations and implement CAPA.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• CRA: Clinical Research Associate
• QA: Quality Assurance
• CRO: Contract Research Organization
• IATA: International Air Transport Association
• ISF: Investigator Site File
• CAPA: Corrective and Preventive Action

Documents

1. Sample Collection Log (Annexure-1)
2. Sample Processing Log (Annexure-2)
3. Sample Storage Log (Annexure-3)
4. Chain of Custody Log (Annexure-4)
5. Sample Deviation Log (Annexure-5)

References

• ICH E6(R2/R3) – Biological Samples in Clinical Trials
• FDA – Biospecimen Management Guidance
• EMA – Human Biological Sample Handling
• CDSCO – Clinical Sample Collection Regulations
• WHO – Guidance on Biological Sample Management

Version: 1.0

Approval Section

Annexures

Annexure-1: Sample Collection Log

Annexure-2: Sample Processing Log

Annexure-3: Sample Storage Log

Annexure-4: Chain of Custody Log

Annexure-5: Sample Deviation Log

Revision History

For more SOPs visit: Pharma SOP